Juan Maria Roldan-Romero

4PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 10, 2026
Integrated signatures define mutational processes in prostate cancer.

|Jul 04, 2020
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.

Juan María Roldan-Romero, María Santos, Javier Lanillos

|Aug 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.

Cristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano

|Jul 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.

Juan M Roldan-Romero, Benoit Beuselinck, María Santos

Pageof 1

Frequent Collaborators

2 joint publications

Cristina Rodríguez-Antona

1 joint publications

Cristina Montero-Conde

1 joint publications

Luis Javier Leandro-García

1 joint publications

Andreas J Gruber